Page last updated: 2024-08-24

lonapalene and masoprocol

lonapalene has been researched along with masoprocol in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kreft, AF; Musser, JH1
Batt, DG; Galbraith, W; Harris, RR; Maynard, GD; Petraitis, JJ; Shaw, JE1
Gawlik, I; Leukel, P; Müller, K; Ziereis, K1
Gürster, D; Müller, K; Piwek, S; Wiegrebe, W1

Reviews

1 review(s) available for lonapalene and masoprocol

ArticleYear
5-lipoxygenase: properties, pharmacology, and the quinolinyl(bridged)aryl class of inhibitors.
    Journal of medicinal chemistry, 1992, Jul-10, Volume: 35, Issue:14

    Topics: Animals; Arachidonate 5-Lipoxygenase; Asthma; Eosinophils; Humans; Inflammation; Leukotriene Antagonists; Lipoxygenase Inhibitors; Lung Diseases; Neutrophils; Quinolines

1992

Other Studies

3 other study(ies) available for lonapalene and masoprocol

ArticleYear
2-substituted-1-naphthols as potent 5-lipoxygenase inhibitors with topical antiinflammatory activity.
    Journal of medicinal chemistry, 1990, Volume: 33, Issue:1

    Topics: Animals; Arachidonate Lipoxygenases; Arachidonic Acid; Arachidonic Acids; Chemical Phenomena; Chemistry; Dermatitis; Ear Diseases; Edema; Leukemia, Basophilic, Acute; Lipoxygenase Inhibitors; Molecular Structure; Naphthols; Rats; Structure-Activity Relationship; Tumor Cells, Cultured

1990
Antipsoriatic anthrones with modulated redox properties. 2. Novel derivatives of chrysarobin and isochrysarobin--antiproliferative activity and 5-lipoxygenase inhibition.
    Journal of medicinal chemistry, 1994, May-27, Volume: 37, Issue:11

    Topics: Administration, Topical; Animals; Anthracenes; Anti-Inflammatory Agents; Antioxidants; Cattle; Cell Division; Cells, Cultured; Humans; Hydroxyeicosatetraenoic Acids; Keratinocytes; Leukotriene B4; Lipid Peroxidation; Liposomes; Lipoxygenase Inhibitors; Malondialdehyde; Molecular Structure; Neutrophils; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship

1994
Antipsoriatic anthrones with modulated redox properties. 1. Novel 10-substituted 1,8-dihydroxy-9(10H)-anthracenones as inhibitors of 5-lipoxygenase.
    Journal of medicinal chemistry, 1993, Dec-10, Volume: 36, Issue:25

    Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Arachidonate 5-Lipoxygenase; Cattle; Lipoxygenase Inhibitors; Neutrophils; Oxidation-Reduction; Structure-Activity Relationship

1993